BOLD vs WELL · P/E 0.1, $24.6M cap vs P/E 100, rev $10.84B
Boundless Bio, Inc. Common Stock (BOLD) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
BOLD does not have a complete income-statement cache yet.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the BOLD and WELL stock pages for the full models.
Not investment advice.